| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.6B | $0.4B | $0.3B | $0.3B | $0.1B | $0.1B | $0.1B | $0.1B |
| Cost of Revenue | — | — | — | — | — | $0.1B | $0.1B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.0B |
| Net Income | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B | $0.1B |
| EPS (Basic) | $15.97 | $6.40 | $0.35 | $0.00 | $-0.62 | $0.71 | $2.99 | $6.87 |
| EPS (Diluted) | $15.34 | $6.23 | $0.33 | $0.00 | $-0.62 | $0.68 | $2.91 | $6.75 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.3B | $2.7B | $2.6B | $2.5B | $2.4B | $1.9B | $1.9B | $1.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $2.7B | $2.2B | $2.1B | $2.0B | $2.0B | $1.5B | $1.6B | $1.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.5B | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.2B | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B |
| Investing Cash Flow | $-0.8B | $-0.1B | $-0.2B | $-0.1B | $-0.5B | $-0.1B | $-0.4B | $-0.3B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.4B | $-0.1B | $0.0B | $0.1B | $0.4B | $-0.1B | $0.2B | $0.2B |